(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.27%) $79.16
(-0.44%) $2.03
(0.04%) $2 310.60
(0.15%) $26.87
(0.26%) $965.10
(-0.03%) $0.932
(-0.08%) $10.98
(-0.05%) $0.797
(-0.02%) $91.11
@ $3.15
Issued: 14 Feb 2024 @ 09:32
Return: 70.48%
Previous signal: Feb 12 - 13:31
Previous signal:
Return: -4.11 %
Live Chart Being Loaded With Signals
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally...
Stats | |
---|---|
Today's Volume | 617 307 |
Average Volume | 598 655 |
Market Cap | 295.25M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $-0.270 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.90 |
ATR14 | $0.0120 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Lefkowitz Steven W | Buy | 30 000 | Stock Option (Right to Buy Common Stock) |
2024-03-05 | Stewart Robert A | Buy | 30 000 | Stock Option (Right to Buy Common Stock) |
2024-03-05 | Kaplan Myron | Buy | 30 000 | Stock Option (Right to Buy Common Stock) |
2024-03-05 | Dillione Janet | Buy | 30 000 | Stock Option (Right to Buy Common Stock) |
2024-03-05 | Dunton Alan W | Buy | 30 000 | Stock Option (Right to Buy Common Stock) |
INSIDER POWER |
---|
93.15 |
Last 95 transactions |
Buy: 4 530 513 | Sell: 123 432 |
Volume Correlation
CorMedix Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CorMedix Inc Correlation - Currency/Commodity
CorMedix Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-205 562 (0.00 %) |
EPS: | $-0.910 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-205 562 (0.00 %) |
EPS: | $-0.910 |
FY | 2022 |
Revenue: | $65 408.00 |
Gross Profit: | $61 674.00 (94.29 %) |
EPS: | $-0.740 |
FY | 2021 |
Revenue: | $190 936 |
Gross Profit: | $41 998.00 (22.00 %) |
EPS: | $-0.750 |
Financial Reports:
No articles found.
CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators